Ion Beam Applications SA (EBR:IBAB)
Belgium · Delayed Price · Currency is EUR 13.14
+0.26 (2.02%)
Apr 10, 2026, 5:35 PM CET
Ion Beam Applications Revenue
In the year 2025, Ion Beam Applications had annual revenue of 620.20M EUR with 24.50% growth. Ion Beam Applications had revenue of 315.30M in the half year ending December 31, 2025, with 6.07% growth.
Revenue
620.20M
Revenue Growth
+24.50%
P/S Ratio
0.62
Revenue / Employee
295.33K
Employees
2,100
Market Cap
384.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.20M | 122.04M | 24.50% |
| Dec 31, 2024 | 498.16M | 31.49M | 6.75% |
| Dec 31, 2023 | 466.67M | 105.40M | 29.17% |
| Dec 31, 2022 | 361.27M | 48.31M | 15.44% |
| Dec 31, 2021 | 312.96M | 1.01M | 0.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.61B |
| Fagron NV | 952.17M |
| European Medical Solutions | 49.47M |
| Nyxoah | 10.02M |
| Hyloris Pharmaceuticals | 8.83M |
| Onward Medical | 5.41M |
| Sequana Medical NV | 105.50K |
Ion Beam Applications News
- 2 years ago - IBA Business Update – Third Quarter 2023 - GlobeNewsWire
- 3 years ago - IBA Reports Half Year 2022 Results - GlobeNewsWire